Global Stroke Therapeutics Pipeline Report, H1 2017 - Review of 84 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Stroke - Pipeline Review, H1 2017" report to their offering.

Stroke - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Stroke (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 9, 22, 15, 1, 87 and 11 respectively. Similarly, the Universities portfolio in Phase III, Preclinical and Discovery stages comprises 1, 31 and 3 molecules, respectively.

Stroke (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Stroke - Overview
  3. Stroke - Therapeutics Development
  4. Stroke - Therapeutics Assessment
  5. Stroke - Companies Involved in Therapeutics Development
  6. Stroke - Drug Profiles
  7. Stroke - Dormant Projects
  8. Stroke - Discontinued Products
  9. Stroke - Product Development Milestones
  10. Appendix

Companies Mentioned

  • AB Science SA
  • Anavex Life Sciences Corp
  • Angion Biomedica Corp
  • Antoxis Ltd
  • ArmaGen Inc
  • Cellular Biomedicine Group Inc
  • CHA Bio & Diostech Co Ltd
  • ContraVir Pharmaceuticals Inc
  • CSPC Pharmaceutical Group Limited
  • D-Pharm Ltd
  • Daiichi Sankyo Company Ltd
  • Glucox Biotech AB
  • Green Cross Corp
  • Huons Co Ltd
  • Immunwork Inc
  • International Stem Cell Corp
  • Jeil Pharmaceutical Co Ltd
  • JN-International Medical Corp
  • JT Pharmaceuticals Inc
  • NeuroVive Pharmaceutical AB
  • New World Laboratories Inc
  • NoNO Inc
  • Panacea Pharmaceuticals Inc
  • Pharmaxis Ltd
  • Pharmicell Co Ltd
  • Phoenix Biotechnology Inc
  • PhytoHealth Corp
  • Pluristem Therapeutics Inc
  • QR Pharma Inc
  • TikoMed AB
  • Verseon Corp
  • Vicore Pharma AB
  • Virogenomics BioDevelopment Inc
  • WhanIn Pharmaceutical Co Ltd
  • Zocere Inc

For more information about this report visit http://www.researchandmarkets.com/research/fz3fll/stroke_pipeline

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Drugs